Cormorant Private Healthcare Fund Ii, Lp - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Avidity Biosciences Inc (RNA). Other recent insider transactions involving Avidity Biosciences Inc (RNA) include a net sale of 189,500 shares made by Arthur A Levin , a net sale of 622,046 shares made by Sarah Boyce , and a net sale of 349,918 shares made by Michael F Maclean .

In summary, during the past 3 months, insiders sold 457,756 shares of Avidity Biosciences Inc (RNA) in total and bought 0 shares, with a net sale of 457,756 shares. During the past 18 months, 1,479,675 shares of Avidity Biosciences Inc (RNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,479,675 shares.

Avidity Biosciences Inc (RNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Atea Pharmaceuticals Inc (AVIR). Other recent insider transactions involving Atea Pharmaceuticals Inc (AVIR) include a net sale of 115,885 shares made by Jean-pierre Sommadossi , a net sale of 17,544 shares made by Bruce Polsky , and a net sale of 15,870 shares made by Maria Arantxa Horga .

In summary, during the past 3 months, insiders sold 57,969 shares of Atea Pharmaceuticals Inc (AVIR) in total and bought 0 shares, with a net sale of 57,969 shares. During the past 18 months, 203,467 shares of Atea Pharmaceuticals Inc (AVIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 203,467 shares.

Atea Pharmaceuticals Inc (AVIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 1,198,445 shares made by Kevin C Tang , and a net sale of 995,000 shares made by Boxer Capital, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,168,973 shares of Rain Oncology Inc (RAIN) were sold and 1,372,418 shares were bought by its insiders, resulting in a net purchase of 203,445 shares.

Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 338,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 2,300,000 shares made by Paradigm Biocapital Advisors Lp .

In summary, during the past 3 months, insiders sold 0 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,048,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,245,932 shares were bought by its insiders, resulting in a net sale of 1,802,142 shares.

Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Erasca Inc (ERAS). Other recent insider transactions involving Erasca Inc (ERAS) include a net purchase of 2,100,000 shares made by Jonathan E Lim , a net purchase of 110,000 shares made by Alexander W. Casdin , and a net purchase of 10,000 shares made by Start Valerie Denise Harding .

In summary, during the past 3 months, insiders sold 0 shares of Erasca Inc (ERAS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Erasca Inc (ERAS) were sold and 2,220,000 shares were bought by its insiders, resulting in a net purchase of 2,220,000 shares.

Erasca Inc (ERAS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Aerovate Therapeutics Inc (AVTE). Other recent insider transactions involving Aerovate Therapeutics Inc (AVTE) include a net sale of 64,255 shares made by Hunter Gillies , a net sale of 131,717 shares made by Benjamin T Dake , and a net sale of 62,449 shares made by Timothy P Noyes .

In summary, during the past 3 months, insiders sold 0 shares of Aerovate Therapeutics Inc (AVTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 391,549 shares of Aerovate Therapeutics Inc (AVTE) were sold and 928,110 shares were bought by its insiders, resulting in a net purchase of 536,561 shares.

Aerovate Therapeutics Inc (AVTE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Design Therapeutics Inc (DSGN). Other recent insider transactions involving Design Therapeutics Inc (DSGN) include a net purchase of 1,420,126 shares made by Arsani William , a net purchase of 26,965 shares made by John P. Schmid , and a net purchase of 21,000 shares made by Rodney W Lappe .

In summary, during the past 3 months, insiders sold 0 shares of Design Therapeutics Inc (DSGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 814,874 shares of Design Therapeutics Inc (DSGN) were sold and 2,296,265 shares were bought by its insiders, resulting in a net purchase of 1,481,391 shares.

Design Therapeutics Inc (DSGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Monte Rosa Therapeutics Inc (GLUE). Other recent insider transactions involving Monte Rosa Therapeutics Inc (GLUE) include a net sale of 1,857,674 shares made by Versant Venture Capital Vi, L.p. , and a net sale of 2,817 shares made by Edmund Dunn .

In summary, during the past 3 months, insiders sold 1,857,674 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 0 shares, with a net sale of 1,857,674 shares. During the past 18 months, 1,860,491 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,860,491 shares.

Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in BioAtla Inc (BCAB). Other recent insider transactions involving BioAtla Inc (BCAB) include a net purchase of 6,000 shares made by Sylvia Mcbrinn , a net purchase of 50,000 shares made by Short Jay M Phd , and a net purchase of 20,000 shares made by Lawrence Steinman .

In summary, during the past 3 months, insiders sold 0 shares of BioAtla Inc (BCAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioAtla Inc (BCAB) were sold and 83,495 shares were bought by its insiders, resulting in a net purchase of 83,495 shares.

BioAtla Inc (BCAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in GreenLight Biosciences Holdings PBC (GRNA). Other recent insider transactions involving GreenLight Biosciences Holdings PBC (GRNA) include a net sale of 9,188,659 shares made by Cormorant Global Healthcare Master Fund, Lp ,

In summary, during the past 3 months, insiders sold 0 shares of GreenLight Biosciences Holdings PBC (GRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,188,659 shares of GreenLight Biosciences Holdings PBC (GRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,188,659 shares.

GreenLight Biosciences Holdings PBC (GRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Environmental Impact Acquisition Corp (ENVIU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Environmental Impact Acquisition Corp (ENVIU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Environmental Impact Acquisition Corp (ENVIU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in MoonLake Immunotherapeutics (MLTX). Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net purchase of 802,051 shares made by Bihua Chen , a net sale of 200,000 shares made by Kristian Reich , and a net sale of 184,740 shares made by Santos Da Silva Jorge .

In summary, during the past 3 months, insiders sold 2,171,000 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 2,171,000 shares. During the past 18 months, 2,655,740 shares of MoonLake Immunotherapeutics (MLTX) were sold and 802,051 shares were bought by its insiders, resulting in a net sale of 1,853,689 shares.

MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.